Literature DB >> 21417186

Nystagmus and reduced visual acuity secondary to drug exposure in utero: long-term follow-up.

Manish Gupta1, Alan O Mulvihill, Gerassimos Lascaratos, Brian W Fleck, Nick D George.   

Abstract

PURPOSE: To investigate nystagmus and other visual system abnormalities among children exposed to opiates and benzodiazepines in utero.
METHODS: Retrospective case series comprising clinical examination and case note review of 25 children with nystagmus and reduced vision who were exposed to controlled drugs during pregnancy.
RESULTS: Twenty-four children were exposed to opiates, of whom 13 were also exposed to diazepam. One child was exposed to diazepam alone. All children had horizontal nystagmus, which was either fine pendular or jerk type. The nystagmus had a latent element in 4 children and 8 adopted a compensatory head posture. Where the time of onset of nystagmus was known, it was always prior to 6 months of age. At least 9 children (36%) had delayed visual maturation. The mean initial logarithm of the minimum angle of resolution binocular best-corrected visual acuity (BCVA) was 0.54 at an average of 22 months of age. Thirteen children were followed up for 6 months or longer and their BCVA improved to 0.4 at an average age of 48 months. The nystagmus was clinically improved in only 5 patients. Electroretinogram testing was normal in the 4 children tested. The only ocular structural abnormality was binocular optic nerve hypoplasia in 2 children.
CONCLUSION: Exposure to opiates and benzodiazepines in utero may be associated with permanent nystagmus and reduced visual acuity. This is most likely the result of insult(s) to the central nervous system rather than the eyes. Copyright 2012, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21417186     DOI: 10.3928/01913913-20110308-01

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  7 in total

Review 1.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

Review 2.  Developmental opioid exposures: Neurobiological underpinnings, behavioral impacts, and policy implications.

Authors:  Samantha S Goldfarb; Gregg D Stanwood; Heather A Flynn; Devon L Graham
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-20

3.  Evidence for the Normalization Effects of Medication for Opioid Use Disorder on Functional Connectivity in Neonates with Prenatal Opioid Exposure.

Authors:  Janelle Liu; Karen Grewen; Wei Gao
Journal:  J Neurosci       Date:  2022-05-12       Impact factor: 6.709

4.  Neural alterations in opioid-exposed infants revealed by edge-centric brain functional networks.

Authors:  Weixiong Jiang; Stephanie L Merhar; Zhuohao Zeng; Ziliang Zhu; Weiyan Yin; Zhen Zhou; Li Wang; Lili He; Jennifer Vannest; Weili Lin
Journal:  Brain Commun       Date:  2022-05-05

5.  Congenital nystagmus in two infants born from mothers exposed to methadone during pregnancy.

Authors:  Francesca Tinelli; Alessandra Gamucci; Roberta Battini; Giovanni Cioni
Journal:  Ital J Pediatr       Date:  2013-07-03       Impact factor: 2.638

6.  Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis.

Authors:  Victoria J Monnelly; Ruth Hamilton; Francesca M Chappell; Helen Mactier; James P Boardman
Journal:  Dev Med Child Neurol       Date:  2018-12-03       Impact factor: 5.449

7.  Enduring consequences of perinatal fentanyl exposure in mice.

Authors:  Jason B Alipio; Adam T Brockett; Megan E Fox; Stephen S Tennyson; Coreylyn A deBettencourt; Dina El-Metwally; Nikolas A Francis; Patrick O Kanold; Mary Kay Lobo; Matthew R Roesch; Asaf Keller
Journal:  Addict Biol       Date:  2020-03-18       Impact factor: 4.280

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.